Phio Pharmaceuticals News

Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Infarinato Robert M.

Sep 13 15:01 ET

Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Freeman Jonathan E

Sep 13 15:01 ET

Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bitterman Robert J

Sep 13 15:01 ET

Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BRADFORD PATRICIA A

Sep 12 16:15 ET

Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ferrara Robert L

Sep 12 16:15 ET

Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lockshin Curtis

Sep 12 16:14 ET

Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Infarinato Robert M.

Aug 15 16:18 ET

Phio Pharmaceuticals | 8-K: Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 14 17:07 ET

Phio Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 14 16:51 ET

Phio Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Infarinato Robert M.

Aug 9 09:07 ET

Phio Pharmaceuticals | 424B3: Prospectus

Aug 5 08:02 ET

Phio Pharmaceuticals | EFFECT: Others

Aug 2 06:05 ET

Phio Pharmaceuticals | 8-K: Current report

Aug 1 08:01 ET

Phio Pharmaceuticals | CORRESP: CORRESP

Jul 30 22:19 ET

Phio Pharmaceuticals | UPLOAD: Others

Jul 29 22:15 ET

Phio Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933

Jul 26 16:35 ET

Phio Pharmaceuticals | 8-K: Current report

Jul 24 16:35 ET

Phio Pharmaceuticals | D: Filing D

Jul 24 12:44 ET

Phio Pharmaceuticals | 8-K: Current report

Jul 12 16:33 ET

Phio Pharmaceuticals | 8-K: Current report

Jul 5 08:01 ET